Effect of Increased CRM197Carrier Protein Dose on Meningococcal C Bactericidal Antibody Response
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Increased CRM197Carrier Protein Dose on Meningococcal C Bactericidal Antibody Response
Authors
Keywords
-
Journal
Clinical and Vaccine Immunology
Volume 19, Issue 4, Pages 551-556
Publisher
American Society for Microbiology
Online
2012-02-16
DOI
10.1128/cvi.05438-11
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: Use as a conjugation protein in vaccines and other potential clinical applications
- (2011) Michael Bröker et al. BIOLOGICALS
- Comparative effects of carrier proteins on vaccine-induced immune response
- (2011) Markus Knuf et al. VACCINE
- Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd Immunity
- (2010) H. Campbell et al. Clinical and Vaccine Immunology
- A Randomized, Multicenter, Open-Label Clinical Trial to Assess the Immunogenicity of a Meningococcal C Vaccine Booster Dose Administered to Children Aged 14 to 18 Months
- (2010) Javier Díez-Domingo et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Immunogenicity of a Reduced Schedule of Pneumococcal Conjugate Vaccine in Healthy Infants and Correlates of Protection for Serotype 6B in the United Kingdom
- (2010) David Goldblatt et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Immunogenicity of a Heptavalent Conjugate Pneumococcal Vaccine Administered Concurrently with a Combination Diphtheria, Tetanus, Five-Component Acellular Pertussis, Inactivated Polio, and Haemophilus influenzae Type b Vaccine and a Meningococcal Group C Conjugate Vaccine at 2, 3, and 4 Months of Age
- (2009) S. J. Moss et al. Clinical and Vaccine Immunology
- Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine
- (2009) R. Borrow et al. Clinical and Vaccine Immunology
- Phase III Comparison of an Investigational Quadrivalent Meningococcal Conjugate Vaccine with the Licensed Meningococcal ACWY Conjugate Vaccine in Adolescents
- (2009) Lisa A. Jackson et al. CLINICAL INFECTIOUS DISEASES
- Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs
- (2009) Caroline L Trotter et al. Expert Review of Vaccines
- Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Different Neisseria meningitidis Serogroup C Conjugate Vaccines
- (2009) Jacek Wysocki et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Immunology of combining CRM197 conjugates for Streptococcus pneumoniae, Neisseria meningitis and Haemophilus influenzae in Chilean infants
- (2009) Rosanna Lagos et al. VACCINE
- Immunogenicity of a Reduced Schedule of Meningococcal Group C Conjugate Vaccine Given Concomitantly with the Prevenar and Pediacel Vaccines in Healthy Infants in the United Kingdom
- (2008) J. Southern et al. Clinical and Vaccine Immunology
- Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity
- (2008) Martin C. J. Maiden et al. JOURNAL OF INFECTIOUS DISEASES
- Two versus three doses of a meningococcal C conjugate vaccine concomitantly administered with a hexavalent DTaP-IPV-HBV/Hib vaccine in healthy infants
- (2008) Heinz-J. Schmitt et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now